These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24475455)

  • 21. Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease.
    Nazar CM
    J Nephropharmacol; 2014; 3(1):15-20. PubMed ID: 28197454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H;
    Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The link between chronic kidney disease and cardiovascular disease.
    Said S; Hernandez GT
    J Nephropathol; 2014 Jul; 3(3):99-104. PubMed ID: 25093157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of diabetic nephropathy in older patients with diabetes mellitus type 2].
    Karić E; Tulumović D; Ramić E; Zildzić M; Tulumović A
    Med Arh; 2008; 62(5-6):261-3. PubMed ID: 19469265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.
    Feodoroff M; Harjutsalo V; Forsblom C; Thorn L; Wadén J; Tolonen N; Lithovius R; Groop PH
    Acta Diabetol; 2016 Aug; 53(4):525-33. PubMed ID: 26668013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical care costs associated with progression of diabetic nephropathy.
    Nichols GA; Vupputuri S; Lau H
    Diabetes Care; 2011 Nov; 34(11):2374-8. PubMed ID: 22025783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients.
    L Gupta K; Sahni N
    J Nephropathol; 2012 Oct; 1(3):134-42. PubMed ID: 24475404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.
    Chen HY; Pan HC; Chen YC; Chen YC; Lin YH; Yang SH; Chen JL; Wu HT
    BMC Complement Altern Med; 2019 Apr; 19(1):81. PubMed ID: 30943956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.
    Fioretto P; Caramori ML; Mauer M
    Diabetologia; 2008 Aug; 51(8):1347-55. PubMed ID: 18528679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
    Ruilope LM; Segura J
    Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy-pathophysiology and management.
    Shumway JT; Gambert SR
    Int Urol Nephrol; 2002; 34(2):257-64. PubMed ID: 12775108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
    Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
    Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection in nephrology patients.
    Rostaing L; Izopet J; Kamar N
    J Nephropathol; 2013 Oct; 2(4):217-33. PubMed ID: 24475454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study.
    Zhou Z; Chaudhari P; Yang H; Fang AP; Zhao J; Law EH; Wu EQ; Jiang R; Seifeldin R
    Diabetes Ther; 2017 Jun; 8(3):555-571. PubMed ID: 28361464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease.
    Mahmoodnia L; Tamadon MR
    J Nephropathol; 2017 Jul; 6(3):105-109. PubMed ID: 28975087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus.
    Marshall SM
    Adv Chronic Kidney Dis; 2014 May; 21(3):267-72. PubMed ID: 24780454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic nephropathy: improving prognosis.
    Friedman EA
    Saudi J Kidney Dis Transpl; 2002; 13(3):281-310. PubMed ID: 18209425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.